ASX - Delayed Quote AUD

Wellfully Limited (WFL.AX)

0.0030 0.0000 (0.00%)
At close: July 21 at 3:02 PM GMT+10
Key Events
Loading Chart for WFL.AX
DELL
  • Previous Close 0.0030
  • Open 0.0030
  • Bid 0.0030 x 1600000
  • Ask 0.0040 x 5500000
  • Day's Range 0.0030 - 0.0030
  • 52 Week Range 0.0015 - 0.0120
  • Volume 725,177
  • Avg. Volume 0
  • Market Cap (intraday) 1.479M
  • Beta (5Y Monthly) -0.90
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date Apr 8, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Wellfully Limited, together with its subsidiaries, engages in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates through two segments, Dermaportation Drug Delivery Technology and Devices. It is involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT and SWISSWELL, as well as third-party collaborations. It serves the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Leederville, Australia.

--

Full Time Employees

June 30

Fiscal Year Ends

Related News

Performance Overview: WFL.AX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

WFL.AX
0.00%
S&P/ASX 200 [XJO]
0.20%

1-Year Return

WFL.AX
70.00%
S&P/ASX 200 [XJO]
3.55%

3-Year Return

WFL.AX
95.08%
S&P/ASX 200 [XJO]
7.53%

5-Year Return

WFL.AX
99.00%
S&P/ASX 200 [XJO]
18.64%

Compare To: WFL.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WFL.AX

Valuation Measures

Annual
As of 4/28/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.23

  • Enterprise Value/EBITDA

    -0.94

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -101.74%

  • Return on Assets (ttm)

    -34.46%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.31M

  • Net Income Avi to Common (ttm)

    -1.34M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    275.61k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    1.6M

Company Insights: WFL.AX